Careium Crecimiento futuro
Future controles de criterios 3/6
Careium is forecast to grow earnings and revenue by 16.5% and 10.2% per annum respectively. EPS is expected to grow by 16.8% per annum. Return on equity is forecast to be 8.8% in 3 years.
Información clave
16.5%
Tasa de crecimiento de los beneficios
16.8%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Medical Equipment | 32.8% |
| Tasa de crecimiento de los ingresos | 10.2% |
| Rentabilidad financiera futura | 8.8% |
| Cobertura de analistas | Low |
| Última actualización | 27 Oct 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2026 | 1,056 | 68 | 63 | 128 | 1 |
| 12/31/2025 | 964 | 56 | 63 | 125 | 1 |
| 12/31/2024 | 869 | 54 | 38 | 89 | 1 |
| 9/30/2024 | 841 | 43 | 56 | 112 | N/A |
| 6/30/2024 | 857 | 45 | 43 | 98 | N/A |
| 3/31/2024 | 841 | 46 | 50 | 103 | N/A |
| 12/31/2023 | 825 | 38 | 62 | 112 | N/A |
| 9/30/2023 | 821 | 40 | -27 | 25 | N/A |
| 6/30/2023 | 780 | 12 | -52 | 3 | N/A |
| 3/31/2023 | 741 | 14 | -63 | -5 | N/A |
| 12/31/2022 | 725 | -11 | -87 | -21 | N/A |
| 9/30/2022 | 691 | -21 | -19 | 45 | N/A |
| 6/30/2022 | 656 | -7 | -20 | 40 | N/A |
| 3/31/2022 | 628 | -19 | -44 | 17 | N/A |
| 12/31/2021 | 588 | 5 | -71 | -20 | N/A |
| 12/31/2020 | 524 | 19 | 3 | 44 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: CARE's forecast earnings growth (16.5% per year) is above the savings rate (1.1%).
Beneficios vs. Mercado: CARE's earnings (16.5% per year) are forecast to grow faster than the Swedish market (15.7% per year).
Beneficios de alto crecimiento: CARE's earnings are forecast to grow, but not significantly.
Ingresos vs. Mercado: CARE's revenue (10.2% per year) is forecast to grow faster than the Swedish market (0.01% per year).
Ingresos de alto crecimiento: CARE's revenue (10.2% per year) is forecast to grow slower than 20% per year.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: CARE's Return on Equity is forecast to be low in 3 years time (8.8%).